Indian Erlotinib Exporters: Complete Supplier Ranking with Market Share — 94 Manufacturers (2026) — TransData Nexus

Q: Who is the largest erlotinib supplier from India?

NATCO PHARMA LIMITED is the largest erlotinib exporter from India with a 20.4% market share and export value of $547.2K.

Q: How many erlotinib suppliers are there in India?

There are 94 active erlotinib exporters in India, collectively shipping $2.7M worth of erlotinib across 336 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top erlotinib suppliers from India?

The top 5 erlotinib suppliers from India — NATCO PHARMA LIMITED, MSN LABORATORIES PRIVATE LIMITED, CIPLA LIMITED, VEXXA LIFESCIENCES PVT. LTD., ALEMBIC PHARMACEUTICALS LIMITED — together control 69.7% of total erlotinib export value from India.

Suresh Sormare

Erlotinib

India Pharmaceutical Trade Intelligence

$2.7M94 Suppliers55 CountriesHS 30049049

ExportsIndia → UNITED STATES21.0%India → THAILAND18.9%

ImportsITALY → India$377.7K BRAZIL → India$19.7K

#1 Supplier: NATCO PHARMA #1 Buyer: ATLANTA MEDICARE

Erlotinib Suppliers from India (2026) — 94 Exporters, $2.7M Market | TransData Nexus | TransData Nexus

Who Exports Erlotinib from India — 94 Suppliers Behind a $2.7M Market

India's erlotinib export market is supplied by 94 active exporters who collectively shipped $2.7M across 336 shipments. NATCO PHARMA LIMITED leads with a 20.4% market share, followed by MSN LABORATORIES PRIVATE LIMITED and CIPLA LIMITED. The top 5 suppliers together control 69.7% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026·

India's Top Erlotinib Suppliers & Exporters — 94 manufacturers, $2.7M export market, top destinations and formulations — Erlotinib supplier data — 94 exporters · $2.7M market · 336 shipmentsTransData Nexus · Indian Customs Data

Top Erlotinib Exporters from India — Ranked by Export Value

NATCO PHARMA LIMITED is the leading erlotinib exporter from India, holding a 20.4% share of the $2.7M market across 336 shipments from 94 exporters. The top 5 suppliers — NATCO PHARMA LIMITED, MSN LABORATORIES PRIVATE LIMITED, CIPLA LIMITED, VEXXA LIFESCIENCES PVT. LTD., ALEMBIC PHARMACEUTICALS LIMITED — collectively control 69.7% of total export value, indicating a moderately concentrated market. Individual shares are: NATCO PHARMA LIMITED (20.4%), MSN LABORATORIES PRIVATE LIMITED (19.8%), CIPLA LIMITED (15.3%), VEXXA LIFESCIENCES PVT. LTD. (9.5%), ALEMBIC PHARMACEUTICALS LIMITED (4.8%).

Top Erlotinib Exporters from India

Ranked by export value · 94 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Erlotinib Exporters from India — Ranked by Export Value. 94 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Erlotinib exporters

Certification and compliance status for top Erlotinib suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
CIPLA LIMITED	Warning Letter, November	Yes, February 2024	No	Not verified	FDA issued a warning letter in November 2023 for CGMP violations at Indore facil
ALEMBIC PHARMACEUTICALS LIMITED	Not Listed	Yes, July 2025	No	Not verified	WHO-GMP compliance confirmed in July 2025 for API Unit I.
RELIANCE LIFE SCIENCES PRIVATE LIMITED	Not Listed	Unknown	No	Not verified	Received clarification letter from CDSCO on June 8, 2022.
SUN PHARMACEUTICAL INDUSTRIES LIMITED	Not Listed	Unknown	No	Not verified	No specific regulatory actions found in available sources.
JODAS EXPOIM PRIVATE LIMITED	Not Listed	Unknown	No	Not verified	No specific regulatory actions found in available sources.

TransData Nexus reviewed the regulatory standing of 5 leading Erlotinib exporters from India. 0 hold US FDA facility approvals, 2 maintain WHO-GMP certification, and 0 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Erlotinib sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% to the nation's bulk drug production. This prominence is bolstered by the presence of major pharmaceutical companies such as NATCO Pharma Limited and MSN Laboratories Private Limited, both leading exporters of Erlotinib. The city's robust infrastructure, including the Hyderabad Pharma City project, further cements its status as a pharmaceutical hub.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations and biogenerics manufacturing. (mediaindia.eu) Vadodara, in particular, hosts Alembic Pharmaceuticals Limited, a key exporter of Erlotinib. The region's focus on formulations is supported by a well-established industrial ecosystem and a skilled workforce, making it a strategic location for pharmaceutical production.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical industry. Companies like Sun Pharmaceutical Industries Limited, headquartered in Mumbai, leverage the region's extensive port facilities and logistical advantages to distribute products like Erlotinib to international markets. The area's proximity to major shipping routes enhances its role in global pharmaceutical trade.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Erlotinib exporters from India

November 2025

M&A

Natco Pharma Limited — Natco Pharma acquires 35.75% stake in Adcock Ingram

In November 2025, Natco Pharma Limited completed the acquisition of a 35.75% stake in Adcock Ingram, a South African pharmaceutical company, for approximately US$226 million. This acquisition led to the delisting of Adcock Ingram from the Johannesburg Stock Exchange. - IMPACT: This strategic move is expected to enhance Natco Pharma's global footprint, potentially increasing its Erlotinib export capabilities.

Impact: This strategic move is expected to enhance Natco Pharma's global footprint, potentially increasing its Erlotinib export capabilities.

March 2025

M&A

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

In March 2025, Sun Pharma announced the acquisition of Checkpoint Therapeutics, a company specializing in immunotherapy and targeted oncology treatments, for $355 million. - IMPACT: This acquisition may bolster Sun Pharma's oncology portfolio, potentially affecting its position in the Erlotinib market.

Impact: This acquisition may bolster Sun Pharma's oncology portfolio, potentially affecting its position in the Erlotinib market.

Common Questions — Erlotinib Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which erlotinib supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, NATCO PHARMA LIMITED leads with 11 recorded shipments worth $547.2K. MSN LABORATORIES PRIVATE LIMITED (32 shipments) and CIPLA LIMITED (4 shipments) are also established high-volume exporters.

Q How many erlotinib manufacturers are there in India?

India has 94 active erlotinib exporters with a combined export market of $2.7M across 336 shipments to 55 countries. The top 5 suppliers hold 69.7% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for erlotinib from India?

Average FOB unit price: $47.90 per unit, ranging from $0.04 to $3896.10. Average shipment value: $8.0K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Erlotinib

Erlotinib

Who Exports Erlotinib from India — 94 Suppliers Behind a $2.7M Market

Top Erlotinib Exporters from India — Ranked by Export Value

Top Erlotinib Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Natco Pharma Limited — Natco Pharma acquires 35.75% stake in Adcock Ingram

Sun Pharmaceutical Industries Limited — Sun Pharma acquires Checkpoint Therapeutics for $355 million

Common Questions — Erlotinib Suppliers from India

Q Which erlotinib supplier from India is the most reliable for bulk orders?

Q How many erlotinib manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for erlotinib from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Sun Pharmaceutical Industries Limited — Sun Pharma merges with Taro Pharmaceuticals for $347.73 million

Analysis Methodology